SAb Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte ...
SAb Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for autoimmune diseases, including its lead program in ...
SAB BIO has announced a $175 million private placement financing to fund its pivotal Phase 2b SAFEGUARD study of SAB-142, aimed at delaying the progression of autoimmune type 1 diabetes (T1D) in newly ...
SAB has launched a new, more modern logo. Its CEO believes better times lie ahead for South Africa thanks to a growing youthful population. A merged Heineken and Distell group could bring more ...
SAB Invest, one of the leading investment firms in the Kingdom, has announced its membership in the International Securities ...
Sab Zada and Jaden Smith seemingly split in August 2024 Charlotte Walsh is an evergreen editor at PEOPLE. She has been contributing to PEOPLE since 2022. Her work has previously appeared in Women's ...
SAN FRANCISCO and PORTLAND, Ore. and BOSTON, Nov. 5, 2025 /PRNewswire/ -- Drug Hunter, the leading knowledge platform for ...
After announcing plans to go gender neutral last fall, the formerly all-female Sablière Society—now rebranded as the Sab Club—inducted a group of 14 men into their ranks this weekend, according to ...
Orchestra BioMed (Nasdaq:OBIO) announced today that it entered into a termination and right of first refusal agreement with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback